Onconova Therapeutics: Onconova Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023

Onconova Therapeutics, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was USD 0.226 million compared to USD 0.226 million a year ago. Net loss was USD 18.95 million compared to USD 18.96 million a year ago. Basic loss per share from continuing operations was USD 0.9 compared to USD 0.91 a year ago. Diluted loss per share from continuing operations was USD 0.9 compared to USD 0.91 a year ago.